Bevacizumab combined with docetaxel or paclitaxel as first-line treatment of HER2-negative metastatic breast cancer

: Tiainen Leena, Tanner Minna, Lahdenperä Outi, Vihinen Pia, Jukkola Arja, Karihtala Peeter, Paunu Niina, Huttunen Teppo, Kellokumpu-Lehtinen Pirkko-Liisa

: 2016

: Anticancer Research

: 36

: 12

: 6431

: 6438

: 8

: 0250-7005

DOI: https://doi.org/10.21873/anticanres.11241

: http://ar.iiarjournals.org/content/36/12/6431.long